Customer Story
How medmix cut third-party review time without growing its compliance team
A global medical device company that built a automated compliance program on a single platform after its IPO.
Eight countries. One platform. No extra headcount.
Results
About medmix
A Swiss-based manufacturer specializing in high-precision delivery devices for healthcare (dental, drug delivery, surgery), consumer goods, and industrial markets
- Industry
- Healthcare, Consumer and Industrial
- HQ
- Switzerland
- Employees
- 2,500+ globally
Book a demo
The Challenge
From inherited systems to independent platform
When medmix separated from its former parent company and listed on the Swiss Stock Exchange, it inherited compliance tools built for a different business. Those tools were not going to scale for a standalone, publicly listed company operating across eight countries.
Rene Keiser, Chief Compliance Officer, runs ethics, data privacy, investigations, and third-party governance for a lean team spread across Switzerland, Brazil, China, Germany, India, Spain, the UK, and the USA. Each country was working with its own processes and tools. Getting a clear picture of third-party risk was slow. Board reporting was manual. Consistency was a goal, not a reality.
"We required a solution that could be deployed quickly, aligned with our operating model, and could be centrally managed. The goal was to move from fragmented local tools to a unified system that provided global visibility while supporting diverse regulatory regimes.
The Approach
A staged rollout built around medmix's governance structure
medmix chose GAN Integrity because it could bring third-party due diligence, whistleblowing, investigations, policies, and training into one place. Critically, the platform could be shaped to fit medmix's structure rather than the other way around.
The redesign started with a three-day workshop between medmix and GAN Integrity to map out requirements, then moved to weekly sessions to build the workflow. Low-risk parties can now be screened and approved in minutes. Higher-risk cases get the attention they need.
The Results
What changed when the platform went live
- Reviews that used to take days now take minutes. The compliance team spends its time on cases that actually need human judgment.
-
The investigations module is built to meet EU Whistleblower Directive requirements for documentation, process, and follow-through
-
The platform screens third parties against sanctions lists on an ongoing basis, covering suppliers and customers across all eight countries.
Board reporting without the prep work
The team builds dashboards directly in the platform. Senior management, the Board, and Audit Committee get what they need without anyone pulling data manually.
Working with GAN Integrity
Things that made the difference
GAN Integrity replaced fragmented local tools with a single platform that provides global visibility. Our Board and Management teams welcomed the transparency.
The flexibility of the platform enabled the setup and configuration of medmix's specific risk profile, rather than a one-size-fits-all setup.
Dedication, knowledge and the business process management skills of the GAN Integrity team was outstanding. We went live within the anticipated timeline.
The solution has strengthened our compliance program while enabling the business to move faster. It allows us to focus where it really matters."
Whats NEXT
Building on a scalable foundation
With a solid foundation in place, medmix is expanding the platform’s scope. The team plans to leverage the Benefit Approval Request module to manage healthcare compliance, pre-approving and tracking interactions such as benefits and support in a transparent way.
Additionally, medmix is exploring ways to support its sustainability reporting. “Our aim is to have a structured, workflow-based tool to collect and consolidate ESG-relevant data across sites,” Rene notes.
Could your compliance program run this efficiently?
See how you can consolidate your TPRM, investigations, and reporting in one platform.